Stephane Bancel, Chief Executive Officer at Moderna, Inc. (MRNA), sold 160,000 shares at $141.18 ($22.4M) on 2023-03-08, disclosed to the SEC on 2023-03-10.
Seasonal sale ($22.4M) by Chief Executive Officer — this insider has traded MRNA in March in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $141.18 | 26,018 | $3.7M | 16.4% |
| 2 | $141.18 | 26,018 | $3.7M | 16.4% |
| 3 | $141.76 | 13,982 | $2.0M | 8.8% |
| 4 | $141.76 | 13,982 | $2.0M | 8.8% |
| 5 | $137.25 | 11,461 | $1.6M | 7.0% |
| 6 | $137.25 | 11,461 |
| $1.6M |
| 7.0% |
| 7 | $137.97 | 7,739 | $1.1M | 4.8% |
| 8 | $137.97 | 7,739 | $1.1M | 4.8% |
| 9 | $139.24 | 3,896 | $542K | 2.4% |
| 10 | $139.24 | 3,896 | $542K | 2.4% |
| 11 | $140.23 | 5,563 | $780K | 3.5% |
| 12 | $140.23 | 5,563 | $780K | 3.5% |
| 13 | $141.30 | 9,232 | $1.3M | 5.8% |
| 14 | $141.30 | 9,232 | $1.3M | 5.8% |
| 15 | $142.26 | 2,109 | $300K | 1.3% |
| 16 | $142.26 | 2,109 | $300K | 1.3% |
| Total | $140.29 avg | 160,000 | $22.4M | 100% |
| Filing → |
| MRNA | SELL | 2024-02-16 | $4.7M | — | Filing → |
| MRNA | SELL | 2023-06-30 | $6.6M | — | Filing → |
| MRNA | SELL | 2023-06-23 | $19.3M | — | Filing → |